Johnson & Johnson to Host Medical Devices & Diagnostics Business Review

NEW BRUNSWICK, N.J., April 23, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Medical Devices & Diagnostics business for the investment community beginning at 9:30 a.m. (Eastern Time) on Thursday, May 22, 2014 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 2:30 p.m.

Dominic J. Caruso, Vice President, Finance and Chief Financial Officer will host the meeting which will feature presentations by Johnson & Johnson's senior management within the Medical Devices and Diagnostics organization.

The agenda for the day will be posted on the Investor Relations website on approximately May 15th.

Investors and other interested parties may access this meeting by visiting the Company's website at www.investor.jnj.com for a simultaneous webcast of the presentations. 

A replay and podcast will be available shortly after the live webcast through www.investor.jnj.com.

 

 

 

SOURCE Johnson & Johnson

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.